Open AccessCoronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients
Author(s) -
Antoine Lafarge,
Asma Mabrouki,
Elise Yvin,
Swann Bredin,
Yannick Binois,
Raphaël Clère-Jehl,
Élie Azoulay
Publication year - 2021
Publication title -
current opinion in critical care, with evaluated medline/current opinion in critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.212
H-Index - 88
eISSN - 1080-8183
pISSN - 1070-5295
DOI - 10.1097/mcc.0000000000000907
Subject(s) - medicine , hematopoietic stem cell transplantation , immunosuppression , disease , population , covid-19 , transplantation , coronavirus , immunology , intensive care medicine , infectious disease (medical specialty) , environmental health
Immunocompromised patients are notably vulnerable to severe coronavirus disease 2019. This review summarizes COVID-19 features and outcomes in autologous and allogeneic hematopoietic stem cell transplantation (HSCT) recipients.